סטילה ישראל - עברית - Ministry of Health

סטילה

teva pharmaceutical industries ltd, israel - tetrahydrozoline hydrochloride - טיפות עיניים - tetrahydrozoline hydrochloride 0.5 mg/ml - tetryzoline - tetryzoline - irritation, burning, reddening, itching of the eye due to allergic or physical causes such as dust, smoke, plants,sun rays.

וי-זולין ישראל - עברית - Ministry of Health

וי-זולין

vitamed pharmaceutical industries ltd - tetrahydrozoline hydrochloride - טיפות - tetrahydrozoline hydrochloride 0.05 %w/v - tetryzoline - tetryzoline - for relief in cases of redness in the eye as a result of irritation, caused by various materials such as dust, smoke, plants, etc.

סטילה סינגלס ישראל - עברית - Ministry of Health

סטילה סינגלס

abic marketing ltd, israel - tetrahydrozoline hydrochloride - טיפות עיניים - tetrahydrozoline hydrochloride 0.05 % - tetryzoline - tetryzoline - irritation, burning, reddening, itching of the eye due to allergic or physical causes such as dust, smoke, plants,sun rays.

וייזין אוריגינל טיפות עיניים ישראל - עברית - Ministry of Health

וייזין אוריגינל טיפות עיניים

j-c health care ltd - tetrahydrozoline hydrochloride - טיפות עיניים - tetrahydrozoline hydrochloride 0.05 % - tetryzoline - tetryzoline - relief from soreness, burning, itching, irritation redness due to congestion of the eyes.

איי ריליף ישראל - עברית - Ministry of Health

איי ריליף

vitamed pharmaceutical industries ltd - tetrahydrozoline hydrochloride - טיפות - tetrahydrozoline hydrochloride 0.05 %w/v - tetryzoline - tetryzoline - for relief in cases of redness in the eye as a result of irritation, caused by various materials such as dust, smoke, plants, etc.

וייזין איי.סי. ישראל - עברית - Ministry of Health

וייזין איי.סי.

j-c health care ltd - tetrahydrozoline hydrochloride; zinc sulfate - טיפות עיניים - tetrahydrozoline hydrochloride 0.05 %w/w; zinc sulfate 0.25 %w/w - tetryzoline, combinations - tetryzoline, combinations - for relief of minor eye irritation caused by the common cold or by allergens including smoke, pollen, dust, plants, etc.

אופטריל ישראל - עברית - Ministry of Health

אופטריל

teva pharmaceutical industries ltd, israel - boric acid; diphenhydramine hydrochloride; naphazoline hydrochloride - טיפות עיניים - boric acid 2.2 %; diphenhydramine hydrochloride 0.1 %; naphazoline hydrochloride 0.025 % - sympathomimetics used as decongestants - allergic conditions of the conjunctiva, conjunctivitis vernalis, conjunctivitis phylactaenulosa, kerato-conjunctivitis, episcleritis.

אזולין ישראל - עברית - Ministry of Health

אזולין

fischer pharmaceuticals ltd - tetrahydrozoline hydrochloride - טיפות עיניים - tetrahydrozoline hydrochloride 0.05 % - sympathomimetics used as decongestants - for the relief of mild ocular irritation caused by various factors such as smoke, dust, pollen, etc.

אלרין AF טבע ישראל - עברית - Ministry of Health

אלרין af טבע

padagis israel agencies ltd, israel - oxymetazoline hydrochloride - תמיסה - oxymetazoline hydrochloride 0.05 %w/v - oxymetazoline

אפיניטור 5 מג ישראל - עברית - Ministry of Health

אפיניטור 5 מג

novartis israel ltd - everolimus - טבליה - everolimus 5 mg - everolimus - everolimus - * treatment of patients with advanced renal cell carcinoma after failure of treatment with sunitinib or sorafenib.* for the treatment of patients with sega associated with tuberous sclerosis (ts) who require therapeutic intervention but are not candidates for curative surgical resection.the effectiveness of afinitor is based on an analysis of change in sega volume. clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been demonstrated.* treatment of progressive neuroendocrine tumors of pancreatic origin (pnet) in patients with unresectable, locally advanced or metastatic disease.the safety and effectiveness of afinitor® in the treatment of patients with carcinoid tumors have not been established.* for the treatment of hormone receptor – positive, her2/neu negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence of progression follwing a non – steroidal aromatase inhibitor.*